Biological researchers need to identify how new drugs and biologics works within cells. To do so, they test these products in cell lines: human cells propagated in lab culture. These cell lines are often genetically altered in order to study a specific protein but current processes take 4-6 months, the modifications are limited, and altered cells are often killed in order to study the protein of interest. ExpressCells has a superior technology that does not have these limitations. We use CRISPR plus our proprietary genetic vector system to create custom cells for research 4X faster. Our living cells can replicate diseases or have proteins glow in multiple colors. Learn more by following us on Twitter at https://twitter.com/expresscells
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Robin Hood... | robinhoodv... |
| - | Ben Frankl... | sep.benfra... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 15.09.2022 | FY 2022: Ben Franklin Approved $11 Million in 48 Companies | To view details about each company, visit our directory page. Tech: Accencio Agora World Asy... | sep.benfra... |
| 18.10.2021 | Ben Franklin Approved $2.1M in 12 Early Stage Companies | CrossBridge has reimagined Chronic Autoimmune Care. A SaaS specialty care platform is designed... | sep.benfra... |
| 19.01.2021 | Ben Franklin Approved $1M in 7 Early Stage Companies | WhipFlip is disrupting the traditionally flawed process 42 million consumers face each year se... | sep.benfra... |
| 02.03.2020 | CY: 2019 Ben Franklin Approved $4.6 Million in 28 Companies | To view details about each company, visit our directory page. Information Technology LeagueSide ... | sep.benfra... |
| 10.09.2019 | FY 2019: Ben Franklin Approved $7.2 Million in 46 Companies | Companies Approved: To view details about each company, visit our directory page. Information ... | sep.benfra... |
| 25.07.2019 | Ben Franklin Approved 1.3M in 9 Early Stage Companies | Avisi is a pre-clinical stage medical devices company developing VisiPlate, a nanotechnology-e... | sep.benfra... |